<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">Brain ischemia</z:e> causes immediate and delayed cell <z:hpo ids='HP_0011420'>death</z:hpo> that is exacerbated by <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies show that hypocretin-1/orexin-A (Hcrt-1) reduces ischemic brain injury, and Hcrt-positive neurons modulate <z:e sem="disease" ids="C0858744" disease_type="Disease or Syndrome" abbrv="">infection-induced</z:e> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we tested the hypothesis that Hcrt plays a protective role against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by modulating <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Orexin/ataxin-3 (AT) mice, a transgenic strain in which Hcrt-producing neurons degenerate in early adulthood, and <z:mp ids='MP_0002169'>wild-type</z:mp> mice were subjected to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume, neurological score, and spontaneous home cage activity were assessed </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> was measured using immunohistochemistry, ELISA, and assessment of cytokine <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:mpath ids='MPATH_124'>Infarct</z:mpath> volumes 24 and 48 hours after MCAO were significantly larger, neurological score was worse, and spontaneous activity decreased in AT compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="7" pm="."><plain>Macrophage/microglial infiltration and myeloperoxidase-positive cells were higher in AT compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="8" pm="."><plain>Pre-MCAO intracerebroventricular injection of Hcrt-1 significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and macrophage/microglial infiltration in both genotypes and improved neurological score in AT mice </plain></SENT>
<SENT sid="9" pm="."><plain>Post-MCAO treatment decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size in both <z:mp ids='MP_0002169'>wild-type</z:mp> and AT mice, but had no effect on neurological score in either genotype </plain></SENT>
<SENT sid="10" pm="."><plain>Microglia express the Hcrt-1 receptor after MCAO </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α production by <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>-stimulated microglial BV2 cells was significantly reduced by Hcrt-1 pretreatment </plain></SENT>
<SENT sid="12" pm="."><plain>Sham AT mice exhibit increased <z:mp ids='MP_0009277'>brain tumor</z:mp> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α and interleukin-6 mRNA, suggesting <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Loss of Hcrt neurons in AT mice resulted in worsened <z:hpo ids='HP_0001297'>stroke</z:hpo> outcomes, which were reversed by administration of exogenous Hcrt-1 </plain></SENT>
<SENT sid="14" pm="."><plain>The mechanism underlying Hcrt-mediated neuroprotection includes attenuation of <z:mp ids='MP_0001845'>inflammatory responses</z:mp> after ischemic insult </plain></SENT>
</text></document>